Erlotinib Teva

Erlotinib Teva is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Teva B.V. and is designed for oral use.

Erlotinib Teva is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins that help cancer cells grow and divide. This medication is often prescribed for patients with advanced or metastatic non-small cell lung cancer and pancreatic cancer. The drug is part of a class of medications known as tyrosine kinase inhibitors, which interfere with the growth and spread of cancer cells.

Common effects of Erlotinib Teva may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss, nausea, and dry skin. These effects can vary in intensity and duration depending on the individual. It is important to monitor any side effects and consult a healthcare provider if they become severe or persistent.

Erlotinib Teva should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Erlotinib Teva may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. This can affect the effectiveness of Erlotinib Teva or other medications. It is also advisable to avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of this medication. Always consult a healthcare provider before starting or stopping any medication.